Skip to main content
Log in

Type 1 diabetes technology management traps in a pediatric patient: not all that glitters is gold

  • Case Report
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Data availability and material

All data underlying the results are available as part of the article, and no additional source data are required.

References

  1. Boughton CK, Hovorka R (2019) Is an artificial pancreas (closed-loop system) for type 1 diabetes effective? Diabet Med 36(3): 279–286. Doi: https://doi.org/10.1111/dme.13816

  2. GP Forlenza O Pinhas-Hamiel DR Liljenquist 2019 Safety evaluation of the minimed 670G system in children 7–13 years of age with type 1 diabetes Diabetes Technol Ther 21 1 11 19 https://doi.org/10.1089/dia.2018.0264

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Richard MB, Revital N, Roy WB, et al, FLAIR Study Group (2021) A comparison of two hybrid closedloop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial. Lancet 397(10270):208–219. Doi: https://doi.org/10.1016/S0140-6736(20)32514-9

  4. C Berget SE Thomas LH Messer 2020 A clinical training program for hybrid closed loop therapy in a pediatric diabetes clinic J Diabetes Sci Technol 14 2 290 296 https://doi.org/10.1177/1932296819835183

    Article  PubMed  Google Scholar 

  5. OJ Collyns RA Meier ZL Betts 2021 Improved glycemic outcomes with medtronic minimed advanced hybrid closed-loop delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes Diabetes Care 44 4 969 975 https://doi.org/10.2337/dc20-2250

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

The authors received no financial support for the research, authorship and/or publication of this article

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Case description was performed by BP, case revision was performed by ST and EC. The first draft of the manuscript was written by BP and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Barbara Piccini.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

Informed consent was obtained from the parents of the patient for being included in the study.

Consent for publication

Patient and patient’s parent consented for publication.

Human and animal rights

This article does not contain any studies with human or animal subjects performed by the any of the authors.

Additional information

Managed By Massimo Federici .

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Piccini, B., Casalini, E., Macucci, C. et al. Type 1 diabetes technology management traps in a pediatric patient: not all that glitters is gold. Acta Diabetol 59, 137–141 (2022). https://doi.org/10.1007/s00592-021-01781-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-021-01781-z

Keywords

Navigation